Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
出版年份 2020 全文链接
标题
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-04-21
DOI
10.1111/bjh.16653
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for the prevention of thromboembolism in Immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study
- (2019) Brigitte Pegourie et al. AMERICAN JOURNAL OF HEMATOLOGY
- Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma
- (2019) Ang Li et al. Journal of the National Comprehensive Cancer Network
- Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
- (2019) Kristen M. Sanfilippo et al. AMERICAN JOURNAL OF HEMATOLOGY
- NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
- (2019) Shaji K. Kumar et al. Journal of the National Comprehensive Cancer Network
- Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens
- (2018) Neill P. F. Storrar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database
- (2017) Aurore Palmaro et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies
- (2017) Weijuan Li et al. JAMA Oncology
- Cardiovascular Complications of Novel Multiple Myeloma Treatments
- (2016) Weijuan Li et al. CIRCULATION
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Guidelines for determination of the number of prior lines of therapy in multiple myeloma
- (2015) S. V. Rajkumar et al. BLOOD
- The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma
- (2014) Monika Joks et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Venous Thromboembolism and Cancer
- (2013) Gregory Piazza CIRCULATION
- Venous Thromboembolism in Hospitalized Patients With Active Cancer
- (2013) Gregory Piazza et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Updated Definition of Stroke for the 21st Century
- (2013) Ralph L. Sacco et al. STROKE
- Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients
- (2012) Tommaso Za et al. BRITISH JOURNAL OF HAEMATOLOGY
- Third Universal Definition of Myocardial Infarction
- (2012) Kristian Thygesen et al. CIRCULATION
- A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
- (2012) M. N. LEVINE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
- (2011) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
- (2010) S. Y. Kristinsson et al. BLOOD
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
- (2008) S. Y. Kristinsson et al. BLOOD
- A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma
- (2008) Lisa K. Hicks et al. CANCER TREATMENT REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started